Journal of Biomedical Science and Engineering

Vol.6 No.8A(2013), Paper ID 36053, 6 pages

DOI:10.4236/jbise.2013.68A1005

 

In vitro differentiation of human umbilical cord-derived mesenchymal stem cells into CD34+ cells via CD34 antibody

 

Shengnan Guo, Libin Guo, Maoxiang Sun, Wenyue Ma, Yujia Lu, Ying Liu

 

Department of Stem Cell Clinical Application Central, Siping Hospital Affiliated to China Medical University, Siping, China Tuhua Bioengineering Company Ltd., Siping, China
Department of Stem Cell Clinical Application Central, Siping Hospital Affiliated to China Medical University, Siping, China
Department of Stem Cell Clinical Application Central, Siping Hospital Affiliated to China Medical University, Siping, China Tuhua Bioengineering Company Ltd., Siping, China
Department of Stem Cell Clinical Application Central, Siping Hospital Affiliated to China Medical University, Siping, China Tuhua Bioengineering Company Ltd., Siping, China
Department of Stem Cell Clinical Application Central, Siping Hospital Affiliated to China Medical University, Siping, China Tuhua Bioengineering Company Ltd., Siping, China
Department of Stem Cell Clinical Application Central, Siping Hospital Affiliated to China Medical University, Siping, China

 

Copyright © 2013 Shengnan Guo, Libin Guo, Maoxiang Sun, Wenyue Ma, Yujia Lu, Ying Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

 

How to Cite this Article


Guo, S. , Guo, L. , Sun, M. , Ma, W. , Lu, Y. and Liu, Y. (2013) In vitro differentiation of human umbilical cord-derived mesenchymal stem cells into CD34+ cells via CD34 antibody. Journal of Biomedical Science and Engineering, 6, 53-58. doi: 10.4236/jbise.2013.68A1005.

Copyright © 2020 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.